Centre hospitalier universitaire
Angers, 49933, France
NCT Number: NCT00485147
The maximal walking distance (MWD) performed on treadmill (TT) remains the gold standard in estimating the walking capacity of patients suffering from peripheral arterial disease (PAD) with intermittent claudication, although treadmills are not accessible to most physicians. We hypothesized that global positioning system (GPS) recordings could monitor community-based outdoor walking and provide valid information on walking capacity in PAD patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Angers, 49933, France
The study has two main objectives, conducted together. Each objective include several phases.
Objective 1: technical validation of GPS measurements in healthy subjects.
phase 1: technical validation of a GPS device to study outdoor walking (completed).
phase 2: comparison and use of various GPS devices (intra- and inter-GPS variability) in the study outdoor walking (on-going).
phase 3: study of several factors that could influence accuracy of GPS measurements as walking speed, environment, sampling frequency and others technical features as the WAAS/EGNOS function (on-going).
Objective 2: Application in PAD patients to study walking capacity under free-living conditions
phase 1: comparison of GPS measurements (maximal walking distance) with the gold standard treadmill measurement of maximal walking distance (completed).
phase 2: analysis of the variability of the walking capacity under free-living conditions from GPS measurements (completed).
phase 3: study of reliability and sensibility (effect of treatment) of GPS measurements (on-going).
phase 4: study of the relationship between laboratory measurements of walking capacity and GPS-derived parameters.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Analyse the clinical change after surgery from GPS measurements and compare it with laboratory measurement.
Time frame: 2 years
Time frame: 2 years
Time frame: 3 years
Time frame: 4 years
Time frame: 4 years
University Hospital, Angers
Other Gov
Study of Human Locomotion With Global Positioning System. Application to Patients With Peripheral Arterial Disease
Acronym: Starter-GPS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06491810
Arterial Occlusive Diseases, Arteriosclerosis
São Paulo, Brazil
View Trial DetailsNCT03204825
Agnosia, Arterial Occlusive Diseases
Glasgow, Strathcylde, United Kingdom
View Trial DetailsNCT04042311
Arterial Occlusive Diseases, Arteriosclerosis
Hull, United Kingdom
View Trial DetailsNCT00537225
Arterial Occlusive Diseases, Arteriosclerosis
View Trial Details